US 6369033
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
expired A61KA61K38/00A61P
Quick answer
US patent 6369033 (Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein) held by Neurocrine Biosciences, Inc. expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61P, A61P25/00, A61P25/28